Wynzora

Wynzora combines betamethasone and calcipotriol for topical treatment of psoriasis. This corticosteroid and vitamin D analog helps reduce inflammation and skin cell overgrowth. Wynzora is applied to affected skin areas as directed. Suitable for adults with mild to moderate plaque psoriasis.

Wynzora is used to treat plaque psoriasis, a chronic skin condition causing red, scaly patches. It works by reducing inflammation and slowing skin cell growth. Wynzora is designed for external use on skin affected by psoriasis. It is not intended for widespread or severe cases without medical guidance.

Wynzora helps relieve itching, redness, and scaling associated with psoriasis. Regular use may improve skin texture and appearance over time. Some users notice reduced plaque thickness and fewer flare-ups. Results vary by individual and may take several weeks to become noticeable.

Wynzora is for external use only and should not be applied to face, groin, or damaged skin. Avoid contact with eyes and mucous membranes. Use only as prescribed and avoid prolonged exposure to sunlight. Keep out of reach of children. Consult a healthcare provider if irritation occurs.

Avoid using Wynzora with other topical steroids or strong skin treatments unless directed. Do not combine with products containing salicylic acid or other potent acids. Inform your doctor about all medications and skin products in use. Avoid alcohol-based products that may dry or irritate the skin.